Q+A CENTER
Latest question:
How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Industry News
Most Read
Most E-mailed
Print Article
Gamma Cameras to Remain Stable and PET to Decline in European Nuclear Medical Imaging Markets
LONDON , April 26 /PRNewswire/ -- The introduction of new technologies is set to revitalise the increasingly mature European nuclear medical imaging markets. Despite relative stability, innovative and enhanced imaging techniques such as SPECT will energise the saturated gamma camera segment. Moreover, PET-CT scanners will rapidly replace existing PET systems, resulting in revenue attenuation.
Frost & Sullivan (http://www.healthcare.frost.com) finds that the European Nuclear Medicine Imaging Systems Markets earned revenues of US $155.7million in 2005 and estimates to reach US $138.9 million in 2010.
"Increased attention towards molecular imaging will be one of the key drivers for the nuclear medicine market," notes Frost & Sullivan IndustryAnalyst, Srividya Badrinarayanan. "As R&D focus shifts towards molecular imaging, the advancements in and the presence of imaging modalities for nuclear imaging would be very essential for its growth."
Molecular imaging is now considered the technology of the future as itprovides detailed information about diseases and methods to treat them. This will promote the uptake of advanced technologies in nuclear medicine imaging.
Saturation in the gamma market can be overcome only through the introduction of new applications. In the case of the PET scanners market, the availability of its radioisotopes will generate additional interest among endusers.
